News for Healthier Living

Researchers Find New Target to Sensitize Pancreatic Tumors to Immunotherapy

* DPY30 acts as an epigenetic regulator to help pancreatic tumors maintain genomic stability * Targeting DPY30 triggers immune cell infiltration and sensitizes tumors to immunotherapy * DPY30 expression could predict which patients are more likely to benefit from immunotherapy * Therapeutic strategies could combine DPY30 inhibition with immunotherapy to improve patient outcomes

April 8, 2026


April 9 2026

April 8 2026

April 7 2026

April 6 2026

April 5 2026

April 4 2026

April 3 2026

April 2 2026

April 1 2026

March 31 2026

March 30 2026

March 29 2026

March 28 2026

March 27 2026

March 26 2026